Nanjing RegeneCore Biotech Co.,Ltφ∑d is established in the Biomedical Valley of♦≈✔∏ National Nanjing Jiangb'​‍‍ei New Area, with a research and office b‍β∑♣ase of nearly 4000 square meters. It i®¥s one of the first research and developme>₹φnt institutions in the field of nano₽♦"$bodies in China. The company'$β↔s international scientific consulting e↔​xpert team has rich experience in the research an≈✔d development of cell t‌δ↔herapy products and clinical appli↓×÷cations, providing strong gu÷≈δarantees for the precise positioning a↓‍ ♥nd success rate of research♣♦★ and development products. Th≤Ωe company has mature and leadi★•​ng nanobody screening t δechnology, and conducts in-depth de↔>♦velopment in multiple § application fields based on this te≥€chnology.